Division of GlaxoSmithKline PLC
Latest From Tesaro Inc.
GlaxoSmithKline said its increasingly streamlined operations are on a growth trajectory, but that capacity constraints mean demand for its popular shingles vaccine will keep outstripping supply.
Chief scientific officer at GSK, Hal Barron, talks about winning hearts and minds of 10,000 R&D employees, and adopting practices from acquired company Tesaro.
Chief scientific offficer Hal Barron talks about winning hearts and minds of 10,000 R&D employees, and adopting practices from acquired company Tesaro.
The latest drug development news and highlights from our US FDA Performance Tracker.
- Specialty Pharmaceuticals
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- GlaxoSmithKline PLC
- Senior Management
Lonnie Moulder, CEO
Timothy Pearson, EVP, CFO
Mary Lynne Hedley, PhD, Pres. & COO
Grant C Bogle, SVP, Chief Commercial Officer
William Aitchison, PhD, SVP, Technical ops
Allene Diaz, SVP, Global Commercial Development
Joseph Farmer, SVP, General Counsel & Corp Secretary
Martin Huber, MD, SVP, CMO
Jennifer Jackson, PhD, SVP, Global RA and QA
Orlando Oliveira, SVP, International
- Contact Info
Phone: (339) 970-0900
1000 Winter St.
Waltham, MA 02451
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.